Literature DB >> 375676

Human macrophage differentiation in vivo and in vitro. A comparison of human peritoneal macrophages and monocytes.

J Hammerstrøm.   

Abstract

Human mononuclear phagocytes isolated from venous blood or sterile peritoneal exudate were cultured in an in vitro system known to induce differentiation of monocytes to macrophages. Morphological and functional studies were performed at different stages of in vitro differentiation, in order to compare the two macrophage populations. Freshly-isolated human peritoneal macrophages (PEC), which are presumed to represent monocytes which have differentiated in vivo in the peritoneal exudate for 1--2 days, showed several signs of increased effector cell function, as compared to the relatively immature blood monocytes. Cell adherence after phagocytosis, ability to degrade ingested 125I-labelled Candida albicans, and ability to suppress DNA-synthesis in a target cell line of human origin, were all found to be greater in the peritoneal cells in early culture. During in vitro differentiation in this system, both PEC and monocytes developed remarkable morphological and functional changes. Cell size and granule content increased considerably. Cell function, measured as phagocytic, digestive and cytostatic ability, increased for both macrophage populations. The differences between the two cell populations in early culture suggest that the functional and morphological changes induced by in vivo differentiation in peritoneal exudate involve changes of the same kind as those induced by in vitro differentiation in our system. The lodging of mononuclear phagocytes in sterile peritoneal exudate does not seem to impair the capacity for further differentiation to any great extent.

Entities:  

Mesh:

Year:  1979        PMID: 375676

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand C        ISSN: 0304-1328


  13 in total

1.  Interferon gamma-induced gene expression of the novel secretory phospholipase A2 type IID in human monocyte-derived macrophages is inhibited by lipopolysaccharide.

Authors:  John Lindbom; Anders G Ljungman; Christer Tagesson
Journal:  Inflammation       Date:  2005-04       Impact factor: 4.092

2.  Human peritoneal macrophages: clinical models of inflammation and potential targets of antiinflammatory drugs.

Authors:  J H Wilson; I L Bonta
Journal:  Agents Actions       Date:  1986-01

3.  Monocyte-mediated drug-dependent cellular cytotoxicity: effects on different WEHI 164 target cell lines.

Authors:  R Austgulen; O Kildahl-Andersen; T Espevik
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  Changes in respiratory burst activity during human monocyte differentiation in suspension culture.

Authors:  J M Zeller; J Caliendo; T F Lint; D J Nelson
Journal:  Inflammation       Date:  1988-12       Impact factor: 4.092

5.  Human monocyte maturation/differentiation during in vitro culture.

Authors:  R A Musson
Journal:  Surv Immunol Res       Date:  1983

6.  Permissiveness of rabbit monocytes and macrophages for herpes simplex virus type 1.

Authors:  S Plaeger-Marshall; L A Wilson; J W Smith
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

7.  Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence.

Authors:  M Shane Smith; Gretchen L Bentz; J Steven Alexander; Andrew D Yurochko
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  Caspase-1 activation and mature interleukin-1β release are uncoupled events in monocytes.

Authors:  Amy J Galliher-Beckley; Li-Qiong Lan; Shelly Aono; Lei Wang; Jishu Shi
Journal:  World J Biol Chem       Date:  2013-05-26

9.  Physicochemical characterization of cytostatic factors released from human monocytes.

Authors:  J Nissen-Meyer; J Hammerstrøm
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

10.  Further studies on the differences in cytotoxicity of human peripheral blood monocytes and bronchoalveolar macrophages for cultured human lung cells.

Authors:  S Swinburne; M Moore; P Cole
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.